It's also used less often than their patients would like, according to a recent study of women who had a myocardial infarction (MI) and were in a long-term relationship.
Researchers performed a retrospective study of Medicare patients ages 65 years and older who were hospitalized with heart failure, acute myocardial infarction, or pneumonia from Jan. ... were identified for acute myocardial infarction at 4,772 hospitals,
Combination therapy versus aspirin alone associated with fewer ischemic events, higher hemorrhage risk after minor stroke or TIA
In a time-to-event analysis, the primary efficacy outcome was a composite of major ischemic events at 90 days, that is, ischemic stroke, myocardial infarction, or death from an ischemic
A novel 1-hour algorithm to rule in or rule out acute myocardial infarction (MI) by incorporating high-sensitivity cardiac troponin T baseline values and changes may have substantially accelerated management,
Also, they were not able to evaluate the associations according to myocardial infarction subtype, severity of AMI, or physical or cognitive function. ... Overall, the study suggests that “promoting late transfer of patients admitted with acute
It probably should be stopped, because the POISE2 trial showed that there was no benefit in continuing aspirin in terms of reducing perioperative myocardial infarction or death, but there was an
Eligible patients include those who have had a myocardial infarction, coronary artery bypass surgery, stable angina, heart valve repair or replacement, percutaneous transluminal coronary angioplasty or coronary stenting, or heart or
There was no correlation between door-to-balloon time for ST-segment–elevation myocardial infarction (STEMI) and door-to-needle time for acute ischemic stroke among hospitals participating in the Get
Patients with heart failure and myocardial infarction are at an increased risk of developing atrial fibrillation. ... Flecainide is contraindicated after a myocardial infarction because it increases the risk of polymorphic ventricular tachycardia.
The group continues to suggest that supplementation is reasonable for secondary prevention of CHD in patients with a recent CHD event (e.g., myocardial infarction) and added a new recommendation for